Literature DB >> 21446341

Fibula metastasis as the presenting feature of vaginal cancer.

W A Tjalma1, J Somville.   

Abstract

BACKGROUND: Metastatic bone involvement in vaginal carcinoma has not been reported in the literature. CASE: A 74-year-old woman was referred for a painful fibula to the orthopedic surgeon. A work-up revealed an isolated metastatic bone lesion in the right fibula of a primary squamous carcinoma of the vagina. Rather surprisingly this lesion had been missed during all previously regular clinical gynecological examinations. Palliative therapy including bone resection and radiotherapy of the metastatic lesion were given.
CONCLUSION: This case highlights: (1) the unique presentation of a vaginal cancer by pain in the lower leg secondary to a metastasis in the fibula; (2) that a speculum examination can mask a mid-vaginal lesion; (3) the importance of aggressive treatment of a solitary bone metastasis in order to provide effective palliation.

Entities:  

Mesh:

Year:  2011        PMID: 21446341

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Bilateral acrometastasis in a case renal cell carcinoma.

Authors:  Raju Vaishya; Vipul Vijay; Abhishek Vaish
Journal:  BMJ Case Rep       Date:  2014-11-03

2.  Solitary fibular metastasis from nonsmall cell lung carcinoma.

Authors:  Mohammad Akram; Samreen Zaheer; Asif Hussain; Shahid A Siddiqui; Ruquiya Afrose; Saifullah Khalid
Journal:  J Cytol       Date:  2017 Apr-Jun       Impact factor: 1.000

3.  Solitary metastasis of gastric cancer to fibula: a case report.

Authors:  Sepideh Hekmat; Tahereh Ghaedian; Hossein Barati; Mansour Movahed
Journal:  Iran J Radiol       Date:  2012-09-17       Impact factor: 0.212

4.  Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

Authors:  Tao Ji; Ramez Eskander; Yifei Wang; Kunkun Sun; Bang H Hoang; Wei Guo
Journal:  World J Surg Oncol       Date:  2014-08-05       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.